Related references
Note: Only part of the references are listed.Efficacy of omalizumab in the treatment of atopic dermatitis: A pilot study
Lee E. Sheinkopf et al.
ALLERGY AND ASTHMA PROCEEDINGS (2008)
Treatment of chronic autoimmune urticaria with omalizumab
Allen P. Kaplan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Steroid-sparing effect of Omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis
Jacquelyn M. Zirbes et al.
PEDIATRIC PULMONOLOGY (2008)
Treatment of Allergic Bronchopulmonary Aspergillosis (ABPA) in CF With Anti-IgE Antibody (Omalizumab)
Adaobi Kanu et al.
PEDIATRIC PULMONOLOGY (2008)
American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology joint task force report on omalizumab-associated anaphylaxis
Linda Cox et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Anti-IgE in allergic asthma and rhinitis: an update
Jaymin B. Morjaria et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Anti-IgE treatment of eosinophil-associated gastrointestinal disorders
Shabnam Foroughi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Effect of omalizumab on patients with chronic urticaria
Sheldon L. Spector et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2007)
IgE and non-IgE-mediated good allergy: treatment in 2007
Mirna Chehade
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody
Cornelis K. van der Ent et al.
THORAX (2007)
Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding
Sven Klunker et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE
Joshua A. Boyce
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Allergic bronchopulmonary aspergillosis
PG Gibson
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients
Marina Buarque de Almeida et al.
PAEDIATRIC RESPIRATORY REVIEWS (2006)
Treatment of recalcitrant atopic dermatitis with omalizumab
JE Lane et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis
TB Casale et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects
JA Poole et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Failure of omalizumab for treatment of severe adult atopic dermatitis
RA Krathen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment):: INNOVATE
M Humbert et al.
ALLERGY (2005)
The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma
J Bousquet et al.
ALLERGY (2005)
Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma
ST Holgate et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Effect of omalizumab in health care workers with occupational latex allergy
F Leynadier et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children
C Rolinck-Werninghaus et al.
ALLERGY (2004)
Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR
AM Vignola et al.
ALLERGY (2004)
Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis
C Bez et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma
JG Ayres et al.
ALLERGY (2004)
Eosinophilic gastrointestinal disorders (EGID)
ME Rothenberg
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Molecular mechanisms in allergy and clinical immunology
SJ Till et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis
P Chervinsky et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2003)
Omalizumab is effective in the long-term control of severe allergic asthma
BQ Lanier et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2003)
Effect of Anti-IgE therapy in patients with peanut allergy
DYM Leung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Omalizumab improves asthma-related quality of life in patients with severe allergic asthma
A Finn et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Rush Hymenoptera venom immunotherapy:: A safe and practical protocol for high-risk patients
G Sturm et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis
MV Kopp et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Allergens and natural rubber proteins
GL Sussman et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Occupational asthma and rhinoconjunctivitis induced by natural rubber latex exposure
JE Fish
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma
R Buhl et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Intranasal steroids and the risk of emergency department visits for asthma
RJ Adams et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis
JM Spergel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study)
C Möller et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis
J Kuehr et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Treating allergic rhinitis in patients with comorbid asthma: The risk of asthma-related hospitalizations and emergency department visits
J Crystal-Peters et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Effect of omalizumab on symptoms of seasonal allergic rhinitis - A randomized controlled trial
TB Casale et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Allergic rhinitis and its impact on asthma
J Bousquet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
W Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
M Solèr et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab)
H Milgrom et al.
PEDIATRICS (2001)
Systemic reactions and fatalities associated with allergen immunotherapy
RF Lockey et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2001)
Mechanisms of autoimmune activation of basophils in chronic urticaria
Y Kikuchi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Pollen-specific rush immunotherapy:: clinical efficacy and effects on antibody concentrations
R Movérare et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2001)
The natural history of peanut allergy
HS Skolnick et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Cellular and immunologic mechanisms in atopic dermatitis
DYM Leung et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Minimising the risks of allergen-specific injection immunotherapy
HJ Malling
DRUG SAFETY (2000)
Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis
E Ädelroth et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
DA Stevens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study
G Mastella et al.
EUROPEAN RESPIRATORY JOURNAL (2000)
Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workers
F Leynadier et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)